GV 2021 Gp, L.P., 10% Owner at Prime Medicine, Inc. (PRME), sold 844,020 shares at $14.08 ($11.9M) on 2023-05-09, disclosed to the SEC on 2023-05-10.
Scheduled sale ($11.9M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.13 | 100,772 | $1.4M | 12.0% |
| 2 | $14.13 | 100,772 | $1.4M | 12.0% |
| 3 | $14.08 | 321,238 | $4.5M | 38.0% |
| 4 | $14.08 | 321,238 | $4.5M | 38.0% |
| Total | $14.09 avg | 844,020 | $11.9M | 100% |
| Filing → |
| PRME | SELL | 2023-06-09 | $586K | — | Filing → |
| PRME | SELL | 2023-06-07 | $1.8M | — | Filing → |
| PRME | SELL | 2023-05-22 | $2.5M | — | Filing → |